Dr. Zibelman on Combinations of Immunotherapy for RCC – OncLive
|
Dr. Zibelman on Combinations of Immunotherapy for RCC
OncLive The combinations with immunotherapy and the oral TKIs are very promising and may be better tolerated. As time goes on, it will be between those combinations and attempting to identify which groups are better for one versus the other, explains Zibelman. |
